Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032 - Growing Use of Biologics and Biosimilars, Technological Advancements, and Active Product Developments

globenewswire.com
PFE Pfizer is mentioned as a leading market player in the drug delivery devices market, which is projected to grow significantly. The article does not provide specific sentiment towards Pfizer's individual performance but lists it among key companies. JNJ Johnson & Johnson is listed as a prominent company shaping the competitive landscape of the drug delivery devices market. The article highlights market growth but doesn't offer specific sentiment for J&J. MMM 3M is identified as a leading market player in the drug delivery devices sector. The article forecasts substantial market growth, positioning 3M within a positive industry trend without specific company sentiment.

Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032 - Growing Use of Biologics and Biosimilars, Technological Advancements, and Active Product Developments Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's offering.

The global drug delivery devices market is projected to expand from USD 492.13 billion in 2024 to USD 760.98 billion by 2032, reflecting a substantial CAGR of 5.66% from 2025 to 2032. This growth is propelled by the increasing prevalence of chronic diseases, heightened demand for self-administration and home healthcare, the growing use of biologics and biosimilars, technological advancements, and active product development by market leaders.

Regional Insights

North America leads the market, driven by the high incidence of chronic diseases and advanced healthcare infrastructure. Significant R&D investments, favorable regulations, and a robust presence of major players bolster this dominance. The region's appetite for self-administration devices and home healthcare solutions further accelerates growth in the U.S. and Canada.

Leading Market Players

The market's competitive landscape is shaped by prominent companies such as Pfizer, Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche, Ltd., Novartis AG, 3M, Bayer AG, GlaxoSmithKline plc., and AstraZeneca PLC. These players leverage their scale, product innovation, and strategic positioning to maintain market leadership.

Technological Innovations

AI advancements are transforming drug delivery, enabling smart, precise, and adaptive systems that enhance therapeutic outcomes. AI-driven nanorobots and intelligent drug release mechanisms represent the forefront of innovation, facilitating targeted and responsive treatment regimens.

Market Drivers

Key Trends and Opportunities

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/1tn2v0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.